Ascent Group LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG

Ascent Group LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,540 shares of the medical equipment provider’s stock after buying an additional 2,182 shares during the quarter. Ascent Group LLC’s holdings in Intuitive Surgical were worth $6,055,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Tobam boosted its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical during the second quarter valued at approximately $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at approximately $30,000. 1248 Management LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, Riggs Asset Managment Co. Inc. grew its stake in shares of Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ISRG. Daiwa Capital Markets upped their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Piper Sandler increased their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Evercore ISI raised their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Wells Fargo & Company increased their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Finally, BTIG Research upped their price target on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $572.63 on Wednesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a market cap of $205.28 billion, a P/E ratio of 75.74, a P/E/G ratio of 5.26 and a beta of 1.68. The stock’s fifty day moving average is $560.07 and its 200 day moving average is $507.87.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.84 EPS. Analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of the stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $193,595.79. This trade represents a 95.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 114,007 shares of company stock valued at $63,533,844. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.